
European Commission authorises second safe and effective vaccine against COVID-19
Published on 5 January 2021
European Commission Press release Brussels, 06 Jan 2021 Today, the European Commission has granted a conditional marketing authorisation (CMA) for the COVID‑19 vaccine developed by Moderna, the second COVID-19 vaccine authorised in the EU.
